Mesenchymal features of the tumor model were corroborated by the expression of SNAI1. 57No significant changes in GLS expression between tumor models and controls suggest that glutamine metabolism, a key feature in tumor progression, remains unaltered in our system.74 This evidence concerns the gene GLS and neoplasm.